{"id":44569,"date":"2022-06-01T16:01:44","date_gmt":"2022-06-01T14:01:44","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/"},"modified":"2022-06-01T16:01:44","modified_gmt":"2022-06-01T14:01:44","slug":"global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/","title":{"rendered":"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5525097\/intratumoral-cancer-therapies-market-insight?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=c5gll5&amp;utm_campaign=1708075+-+Global+Intratumoral+Cancer+Therapies+Market+Report+2022%3A+Epidemiology+and+Market+Forecast+to+2032&amp;utm_exec=cari18prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Intratumoral Cancer Therapies &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report delivers an in-depth understanding of the Intratumoral Cancer Therapies, historical and forecasted epidemiology as well as the Intratumoral Cancer Therapies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/p>\n<p>\nThe report provides current treatment practices, emerging drugs, Intratumoral Cancer Therapies market share of the individual therapies, current and forecasted market size from 2019 to 2032 segmented by seven major markets. The report also covers current Intratumoral Cancer Therapies treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.\n<\/p>\n<p>\n<strong>Geography Covered<\/strong>\n<\/p>\n<ul>\n<li>\nThe United States\n<\/li>\n<li>\nEU5 (Germany, France, Italy, Spain, and the United Kingdom)\n<\/li>\n<li>\nJapan\n<\/li>\n<\/ul>\n<p>\n<strong>Study Period:<\/strong> 2019-2032\n<\/p>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe report covers the descriptive overview of Intratumoral Cancer Therapies, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies\n<\/li>\n<li>\nComprehensive insight has been provided into the Intratumoral Cancer Therapies epidemiology and treatment in the 7MM\n<\/li>\n<li>\nAdditionally, an all-inclusive account of both the current and emerging therapies for Intratumoral Cancer Therapies are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape\n<\/li>\n<li>\nA detailed review of Intratumoral Cancer Therapies market; historical and forecasted is included in the report, covering drug outreach in the 7MM\n<\/li>\n<li>\nThe report provides an edge while developing business strategies, by understanding trends shaping and driving the global Intratumoral Cancer Therapies market\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\nIn the coming years, Intratumoral Cancer Therapies market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market\n<\/li>\n<li>\nThe companies and academics are working to assess challenges and seek opportunities that could influence Intratumoral Cancer Therapies R&amp;D. The therapies under development are focused on novel approaches to treat\/improve the disease condition\n<\/li>\n<li>\nMajor players are involved in developing therapies for Intratumoral Cancer Therapies. Launch of emerging therapies will significantly impact the Intratumoral Cancer Therapies market\n<\/li>\n<li>\nA better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Intratumoral Cancer Therapies\n<\/li>\n<li>\nThe in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities\n<\/li>\n<\/ul>\n<p>\n<strong>Report Insights<\/strong>\n<\/p>\n<ul>\n<li>\nPatient Population\n<\/li>\n<li>\nTherapeutic Approaches\n<\/li>\n<li>\nIntratumoral Cancer Therapies Pipeline Analysis\n<\/li>\n<li>\nIntratumoral Cancer Therapies Market Size and Trends\n<\/li>\n<li>\nMarket Opportunities\n<\/li>\n<li>\nImpact of upcoming Therapies\n<\/li>\n<\/ul>\n<p>\n<strong>Intratumoral Cancer Therapies Report Key Strengths<\/strong>\n<\/p>\n<ul>\n<li>\n11 Years Forecast\n<\/li>\n<li>\n7MM Coverage\n<\/li>\n<li>\nIntratumoral Cancer Therapies Epidemiology Segmentation\n<\/li>\n<li>\nKey Cross Competition\n<\/li>\n<li>\nHighly Analyzed Market\n<\/li>\n<li>\nDrugs Uptake\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5525097\/intratumoral-cancer-therapies-market-insight?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=c5gll5&amp;utm_campaign=1708075+-+Global+Intratumoral+Cancer+Therapies+Market+Report+2022%3A+Epidemiology+and+Market+Forecast+to+2032&amp;utm_exec=cari18prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/iexwei<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#108;&#x74;&#x6f;&#x3a;pr&#101;&#115;&#x73;&#x40;&#x72;&#x65;se&#97;&#114;&#x63;&#x68;&#x61;&#x6e;d&#109;&#97;&#114;&#x6b;&#x65;&#x74;s&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;o&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Intratumoral Cancer Therapies &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report delivers an in-depth understanding of the Intratumoral Cancer Therapies, historical and forecasted epidemiology as well as the Intratumoral Cancer Therapies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44569","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Intratumoral Cancer Therapies &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report delivers an in-depth understanding of the Intratumoral Cancer Therapies, historical and forecasted epidemiology as well as the Intratumoral Cancer Therapies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-01T14:01:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-01T14:01:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/\"},\"wordCount\":604,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005885\\\/en\\\/1473142\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/\",\"name\":\"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005885\\\/en\\\/1473142\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-01T14:01:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005885\\\/en\\\/1473142\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601005885\\\/en\\\/1473142\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Intratumoral Cancer Therapies &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report delivers an in-depth understanding of the Intratumoral Cancer Therapies, historical and forecasted epidemiology as well as the Intratumoral Cancer Therapies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-01T14:01:44+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 &#8211; ResearchAndMarkets.com","datePublished":"2022-06-01T14:01:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/"},"wordCount":604,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/","name":"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg","datePublished":"2022-06-01T14:01:44+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220601005885\/en\/1473142\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-intratumoral-cancer-therapies-market-report-2022-epidemiology-and-market-forecast-to-2032-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Intratumoral Cancer Therapies Market Report 2022: Epidemiology and Market Forecast to 2032 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44569"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44569\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}